Bayer Aktiengesellschaft (SIX: BAYN.SW) AI-Powered Stock Analysis
See how Bayer Aktiengesellschaft scores across key metrics like financial growth, valuation, and market position on the SIX, using AI-driven evaluation.
BAYN.SW●SIX
HealthcareDrug Manufacturers - General
CHF46.34
CHF0.00(0.00%)
Swiss Market opens in 0h 15m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerBayer Aktiengesellschaft (SIX: BAYN.SW) Stock Overall Grade
Bayer Aktiengesellschaft's grade for its SIX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Bayer Aktiengesellschaft's overall SIX stock rating.
Forecast
B+Score
75/100Financial Growth
B+Score
70/100Fundamental Growth
CScore
48/100Key Ratios
C+Score
53/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Bayer Aktiengesellschaft (SIX: BAYN.SW) AI-Powered Stock Analysis
On the SIX, BAYN.SW demonstrates Good performance with an overall Forecast Score of 75/100 (B+), reflecting high confidence in its potential. Financial Growth (70/100, B+) and Fundamental Growth (48/100, C) highlight its stability, while Key Ratios (53/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the SIX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(SIX: BAYN.SW) Component Analysis Explained
Understand the key factors behind each Bayer Aktiengesellschaft (SIX: BAYN.SW) stock grade, including financials, comparisons, and forecasts.